Association of ki67 and tumor marker p53 in locally advanced breast cancer patients and evaluation of response to neoadjuvant chemotherapy: a survey in South Iran

PURPOSE: Heterogeneity of breast cancer, the most common cancer in women, complicates approach to its treatment. Neoadjuvant chemotherapy (NAC) in the treatment of locally advanced breast cancer (LABC) with the endpoint of achieving pathologic complete response (pCR) is not always successful. The pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Firouzabadi, Dena, Rezvani, Alireza, Dehghanian, Amirreza, Mahmoudi, Laleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628949/
https://www.ncbi.nlm.nih.gov/pubmed/31372050
http://dx.doi.org/10.2147/CMAR.S203831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628949/
https://www.ncbi.nlm.nih.gov/pubmed/31372050
http://dx.doi.org/10.2147/CMAR.S203831

Ejemplares similares